Article Text

PDF
PTH-311 The significance of a positive lymph node at the circumferential resection margin in rectal cancer – does it reduce survival?
  1. N Green1,
  2. P Sarmah1,
  3. G Langman1,
  4. K Chandrakumaran2,
  5. H Youssef1
  1. 1Heart of England NHS Foundation Trust, Birmingham, Birmingham
  2. 2Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK

Abstract

Introduction It is recognised that following rectal cancer resection, a threatened or involved circumferential resection margin (CRM) is associated with increased local recurrence rates. However the significance of a pathological positive lymph node (LN) threatening or involving the CRM remains unclear. The aim of this study was to investigate whether a CRM threatened with a positive lymph node was as significant as for a threatened margin with tumour. The effect of a positive margin on local recurrence, distant recurrence, overall survival and disease-free survival is examined.

Method From April 2005 to July 2013, a prospectively collected database was used, from a single pathologist with a particular interest in rectal cancer. Data was collected on patients with a threatened or involved CRM, defined as cancer within 1mm of the margin. Data was collected on demographics, type of surgery, lymph node yield, the type of CRM involvement (LN/tumour), local and distant recurrence (LR and DR), overall survival (OS) and disease-free survival (DFS).

Results From a total of 303 patients, complete data was available for 280 patients: 195male, 86 female; median age 69 (range 23–89). 90 patients had APR and 191 anterior resection. Median LN yield was 41 (range 9–122) 33/281 patients (11.7%) had a positive margin: 16 patients had tumour at the CRM, 13 patients had involved LN and 4 patients involved nerve or blood vessels. Median follow-up was 30 months (range 0–80). In patients with a positive CRM, LR occurred in 6/33 (18.1%) (1 from LN and 5 from tumour) and DR in 12/33 (36.3%) (5 from LN and 7 from tumour). In patients with negative CRM, LR was 17/248 (6.9%) and DR was 26/248 (10.5%). Kaplan Meier predicted 3 and 5-year OS for negative CRM was 84.6 and 75.1% vs. 74.1% and 49.4% for LN at CRM versus 37.5% and 20.0% for tumour at CRM. OS was significantly lower for tumour at CRM than negative CRM (p = 0.001) but no significant difference for LN at CRM (p = 0.209). Kaplan Meier predicted 3 and 5-year DFS for negative CRM was 76.4% and 65.3% vs. 53.8% and 43.1% for LN at CRM versus 25% and 18.8%for tumour at CRM. DFS was significantly lower for tumour at CRM than negative CRM (p = 0.001) but no significant difference for LN at CRM (p = 0.075).

Conclusion A positive LN at the CRM is not associated with high rates of local recurrence (8%) but did result in distant recurrence in 38% patients. OS and DFS were worse for patients with a positive CRM due to tumour at the margin compared with patients with a negative CRM. However, despite a trend towards lower survival, having a positive LN at the CRM is not associated with significantly reduced OS or DFS.

Disclosure of interest None Declared.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.